🚀 VC round data is live in beta, check it out!

Optiscan Imaging Valuation Multiples

Discover revenue and EBITDA valuation multiples for Optiscan Imaging and similar public comparables like Senzime, Genasys, Outset Medical, AOTI and more.

Optiscan Imaging Overview

About Optiscan Imaging

Optiscan Imaging Ltd is engaged in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications. Its technology offers real-time, 3D, in vivo imaging at the single-cell level, in a non-destructive manner that enables clinicians to make immediate informed decisions. Its products include InVivage, ViewnVivo, and Customisation. Its geographical segments include Australia, Germany, Norway, China, and the United States.


Founded

1997

HQ

Australia

Employees

33

Financials (FY)

Revenue: $679K
EBITDA: ($4M)

EV

$70M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Optiscan Imaging Financials

Optiscan Imaging reported last fiscal year revenue of $679K and negative EBITDA of ($4M).

In the same fiscal year, Optiscan Imaging generated $342K in gross profit, ($4M) in EBITDA losses, and had net loss of ($5M).


Optiscan Imaging P&L

In the most recent fiscal year, Optiscan Imaging reported revenue of $679K and EBITDA of ($4M).

Optiscan Imaging is unprofitable as of last fiscal year, with gross margin of 50%, EBITDA margin of (613%), and net margin of (663%).

See analyst estimates for Optiscan Imaging
Last FY202320242025202620272028
Revenue$679K$1M$751K$679K
Gross Profit$342K$626K$396K$342K
Gross Margin50%62%53%50%
EBITDA($4M)($3M)($4M)($4M)
EBITDA Margin(613%)(332%)(536%)(613%)
EBIT Margin(985%)(483%)(844%)(985%)
Net Profit($5M)($4M)($4M)($5M)
Net Margin(663%)(367%)(587%)(663%)

Financial data powered by Morningstar, Inc.

Optiscan Imaging Stock Performance

Optiscan Imaging has current market cap of $82M, and enterprise value of $70M.

Market Cap Evolution


Optiscan Imaging's stock price is $0.08.

Optiscan Imaging share price decreased by 25.9% in the last year.

See more trading valuation data for Optiscan Imaging
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$70M$82M3.9%25.6%-25.9%$-0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Optiscan Imaging Valuation Multiples

Optiscan Imaging trades at 103.6x EV/Revenue multiple, and (16.9x) EV/EBITDA.

See NTM and 2027E valuation multiples for Optiscan Imaging

Optiscan Imaging Financial Valuation Multiples

As of May 1, 2026, Optiscan Imaging has market cap of $82M and EV of $70M.

Optiscan Imaging has a P/E ratio of (18.2x).

Last FY202320242025202620272028
EV/Revenue103.6x69.6x93.6x103.6x
EV/EBITDA(16.9x)(21.0x)(17.5x)(16.9x)
EV/EBIT(10.5x)(14.4x)(11.1x)(10.5x)
EV/Gross Profit205.6x112.3x177.9x205.6x
P/E(18.2x)(22.1x)(18.6x)(18.2x)
EV/FCF(15.6x)(21.7x)(16.3x)(15.6x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Optiscan Imaging Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Optiscan Imaging Margins & Growth Rates

In the most recent fiscal year, Optiscan Imaging reported gross margin of 50%, EBITDA margin of (613%), and net margin of (663%).

See estimated margins and future growth rates for Optiscan Imaging

Optiscan Imaging Margins

Last FY20242025202720282029
Gross Margin50%53%50%
EBITDA Margin(613%)(536%)(613%)
EBIT Margin(985%)(844%)(985%)
Net Margin(663%)(587%)(663%)
FCF Margin(662%)(576%)(662%)

Optiscan Imaging Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(26%)(10%)
Gross Profit Growth(37%)(13%)
EBITDA Growth20%3%
EBIT Growth30%5%
Net Profit Growth19%2%
FCF Growth33%4%

Data powered by FactSet, Inc. and Morningstar, Inc.

Optiscan Imaging Operational KPIs

Optiscan Imaging's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.2M for the same period.

Access forward-looking KPIs for Optiscan Imaging
Last FY202320242025202620272028
Revenue per Employee$0.0M
Opex per Employee$0.2M
G&A Expenses to Revenue455%288%423%455%
R&D Expenses to Revenue535%224%427%535%
Opex to Revenue1035%545%897%1035%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Optiscan Imaging Competitors

Optiscan Imaging competitors include Senzime, Genasys, Outset Medical, AOTI, Meditera, Agfa-Gevaert, SomnoMed, Sera Prognostics, BioStem Technologies and Austco Healthcare.

Most Optiscan Imaging public comparables operate across Medical Devices, Test & Measurement, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Senzime6.4x5.6x(6.7x)(8.2x)
Genasys2.2x1.5x(7.3x)(77.9x)
Outset Medical0.1x0.1x(0.2x)(0.3x)
AOTI1.3x11.5x
Meditera1.1x15.4x
Agfa-Gevaert0.1x0.1x2.6x2.6x
SomnoMed1.0x0.9x13.2x10.2x
Sera Prognostics482.8x187.2x(1.3x)(1.1x)

This data is available for Pro users. Sign up to see all Optiscan Imaging competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Optiscan Imaging

When was Optiscan Imaging founded?Optiscan Imaging was founded in 1997.
Where is Optiscan Imaging headquartered?Optiscan Imaging is headquartered in Australia.
How many employees does Optiscan Imaging have?As of today, Optiscan Imaging has over 33 employees.
Is Optiscan Imaging publicly listed?Yes, Optiscan Imaging is a public company listed on Australian Securities Exchange.
What is the stock symbol of Optiscan Imaging?Optiscan Imaging trades under OIL ticker.
When did Optiscan Imaging go public?Optiscan Imaging went public in 1997.
Who are competitors of Optiscan Imaging?Optiscan Imaging main competitors include Senzime, Genasys, Outset Medical, AOTI, Meditera, Agfa-Gevaert, SomnoMed, Sera Prognostics, BioStem Technologies, Austco Healthcare.
What is the current market cap of Optiscan Imaging?Optiscan Imaging's current market cap is $82M.
What is the current revenue of Optiscan Imaging?Optiscan Imaging's last fiscal year revenue is $679K.
What is the current EV/Revenue multiple of Optiscan Imaging?Current revenue multiple of Optiscan Imaging is 103.6x.
Is Optiscan Imaging profitable?No, Optiscan Imaging is not profitable.
How many companies Optiscan Imaging has acquired to date?Optiscan Imaging hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Optiscan Imaging has invested to date?Optiscan Imaging hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Optiscan Imaging

Lists including Optiscan Imaging

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial